Horizon Therapeutics Public Limited Company (HZNP) financial statements (2021 and earlier)

Company profile

Business Address CONNAUGHT HOUSE, 1ST FLOOR
DUBLIN, 4
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,0801,076959751509860
Cash and cash equivalents2,0801,076959751509860
Restricted cash and investments443772
Receivables660409465367306210
Inventory, net of allowances, customer advances and progress billings7554516217518
Inventory7554516217518
Prepaid expense 136 268
Advances on inventory purchases13831    
Other undisclosed current assets1141006543238
Total current assets:3,0701,6861,5481,2301,0461,106
Noncurrent Assets
Operating lease, right-of-use asset 40
Property, plant and equipment1893020202314
Intangible assets, net (including goodwill)2,1972,1162,5522,8763,2191,943
Goodwill414414426426446254
Intangible assets, net (excluding goodwill)1,7831,7032,1252,4492,7731,689
Deferred income tax assets56118
Other noncurrent assets5648233629
Other undisclosed noncurrent assets 497331(5)
Total noncurrent assets:3,0022,7502,5982,9363,2461,961
TOTAL ASSETS:6,0734,4364,1464,1664,2923,067
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities523257236173235117
Accounts payable382230355217
Accrued liabilities486235206138183100
Debt 4 1184
Liability for uncertainty in income taxes 22   
Deferred revenue and credits731
Other undisclosed current liabilities352460524567360235
Total current liabilities:876723762757606358
Noncurrent Liabilities
Long-term debt and lease obligation 1,3991,8971,8911,800857
Long-term debt, excluding current maturities 1,3531,8971,8911,800857
Operating lease, liability 47
Liabilities, other than long-term debt168102167249361138
Deferred revenue and credits1089
Deferred compensation liability, classified 138731
Deferred tax liabilities, net94158297113
Deferred income tax liabilities66 
Liability for uncertainty in income taxes 910685
Other liabilities102805568469
Other undisclosed noncurrent liabilities1,00326267278261401
Total noncurrent liabilities:1,1721,5272,3302,4182,4221,396
Total liabilities:2,0472,2513,0923,1753,0281,754
Stockholders' equity
Stockholders' equity attributable to parent4,0252,1851,0549911,2641,313
Common stock000000
Treasury stock, value(5)(5)(5)(5)(5)(5)
Additional paid in capital4,2462,7982,3752,2492,1192,002
Accumulated other comprehensive loss(0)(2)(2)(1)(3)(3)
Accumulated deficit(216)(606)(1,315)(1,252)(848)(681)
Total stockholders' equity:4,0252,1851,0549911,2641,313
TOTAL LIABILITIES AND EQUITY:6,0734,4364,1464,1664,2923,067

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues2,2001,3001,2081,056981757
Revenue, net1,056981757
Cost of revenue
(Cost of Goods and Services Sold)
(533)(362)(422)(546)(393)(220)
Gross profit:1,668938785510588538
Operating expenses(1,178)(811)(783)(902)(735)(482)
Operating income (loss):4901272(392)(147)55
Nonoperating expense(88)(147)(122)(121)(81)(188)
Interest and debt expense(32)(59)   (9)
Other undisclosed income from continuing operations before equity method investments, income taxes3259   9
Income (loss) from continuing operations before equity method investments, income taxes:402(20)(119)(513)(228)(133)
Income from equity method investments1     
Other undisclosed loss from continuing operations before income taxes(1)     
Income (loss) from continuing operations before income taxes:402(20)(119)(513)(228)(133)
Income tax expense (benefit)(12)5934510361172
Net income (loss) available to common stockholders, basic:390573(74)(411)(167)40
Dilutive securities, effect on basic earnings per share390595    
Net income (loss) available to common stockholders, diluted:7801,168(74)(411)(167)40

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):390573(74)(411)(167)40
Other comprehensive income (loss)2(0)(1)2(0)2
Comprehensive income (loss), net of tax, attributable to parent:392573(75)(408)(167)41

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: